Lidex (Fluocinonide Topical) - Summary

LIDEX SUMMARY

LIDEX^®
(fluocinonide)
Gel 0.05%

LIDEX^® (fluocinonide) Gel 0.05% is intended for topical administration. The active component is the corticosteroid fluocinonide, which is the 21-acetate ester of fluocinolone acetonide.

LIDEX Gel is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

See all Lidex indications & dosage >>

LIDEX NEWS HIGHLIGHTS

Published Studies Related to Lidex (Fluocinonide Topical)

An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis. [2006.12]

A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses. [2008.06]

In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle. [2008.01]

more >>

Clinical Trials Related to Lidex (Fluocinonide Topical)

Sorafenib-Induced Rash Treatment [Recruiting]

more >>